

Professor Hanefeld recommends an individualised therapy taking into account the risk/benefit balance for each patient. Professor Hanefeld works on type 2 diabetes. While no lifestyle changes can lower the risk of type 1 diabetes, healthy eating, regular exercise and a healthy body weight can delay, prevent or even reverse the development of type 2 diabetes, which is the most common type in the United Kingdom for example, around 90% of all adults with diabetes have type 2. In type 2 diabetes, the body does not produce enough insulin, or the body’s cells are resistant to insulin and therefore do not react to it. In type 1 diabetes, the body’s immune system attacks and destroys the cells that produce insulin.

Because there is not enough insulin or because it is dysfunctional, glucose is not moved into cells and broken down into energy. Visual Generation/ĭiabetes is a lifelong condition that causes blood sugar level to be too high (hyperglycaemia). Dysregulations can have severe consequences. Produced by the ꞵ-cells of the pancreas, insulin is essential to control the amount of sugar in the blood. When food including carbohydrates is digested and nutrients enter the bloodstream, a hormone called insulin is responsible for moving glucose out of the blood and into cells, where it is broken down to generate energy. carbohydrates, and more specifically glucose, is the body’s preferred source of energy. Diabetes therapy: research, treatment and education of diabetes and related disorders, 11(8), 1645–1666. Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update. This abstract is based on the following article and the references it contains: Hanefeld M., Fleischmann H., Siegmund T., & Seufert J. Professor Markolf Hanefeld suggests that an individualised approach to start timely insulin therapy on the basis of risk/benefit balance is essential. Severe hypoglycaemia may trigger arrhythmias and cardiovascular events. While insulin can efficiently lower blood sugar levels and protect pancreatic ꞵ-cells, it can also cause harmful side effects such as hypoglycaemia and weight gain.
